Table 1.
RQS checkpoint | RQS item number and name | Description and (points) | Mode |
---|---|---|---|
First | Item 1: image protocol quality | Well-documented protocol (+1) AND/OR publicly available protocol (+1) | 1 |
Second | Item 2: multiple segmentation | Testing feature robustness to segmentation variability, e.g., different physicians/algorithms/software (+1) | 0 |
Item 3: phantom study | Testing feature robustness to scanner variability, e.g., different vendors/scanners (+1) | 0 | |
Item 4: multiple time points | Testing feature robustness to temporal variability, e.g., organ movement/expansion/shrinkage (+1) | 0 | |
Third | Item 5: feature reduction | Either feature reduction OR adjustment for multiple testing is implemented (+ 3); otherwise, (−3) | 3 |
Item 6: multivariable analysis | Non-radiomic feature are included in/considered for model building (+1) | 0 | |
Item 7: Biological correlates | Detecting and discussing correlation of biology and radiomic features (+1) | 0 | |
Item 8: cut-off analysis | Determining risk groups by either median, pre-defined cut-off, or continuous risk variable (+1) | 0 | |
Item 9: discrimination statistics | Discrimination statistic and its statistical significance are reported (+ 1); a resampling technique is also applied (+1) | 2 | |
Item 10: calibration statistics | Calibration statistic and its statistical significance are reported (+ 1); a resampling technique is also applied (+1) | 0 | |
Item 11: prospective design | Prospective validation of a radiomics signature in an appropriate trial (+7) | 0 | |
Item 12: validation | Validation is missing (−5) OR internal validation (+2) OR external validation on single dataset from one institute (+3) OR external validation on two datasets from two distinct institutes (+4) OR validation of a previously published signature (+4) validation is based on three or more datasets from distinct institutes (+5) | 2 | |
Item 13: comparison to “gold standard” | Evaluating model’s agreement with/superiority to the current “gold standard” (+2) | 0 | |
Item 14: potential clinical application | Discussing model applicability in a clinical setting (+2). | 2 | |
Item 15: cost-effectiveness analysis | Performing a cost-effectiveness of the clinical application (+1) | 0 | |
Item 16: open science and data | Open source scans (+1) AND/OR open source segmentations (+1) AND/OR open source code (+1) AND/OR open source representative features and segmentations (+1) | 0 |
RQS radiomics quality score